A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...

Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Despite the significance of immune checkpoint inhibitors (ICIs) in solid tumor treatment, identifying ICI-sensitive populations remains a challenge. Mutations in DNA damage response (DDR) pathway ...

A study has discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway. A study led by researchers at ...

FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...

New molecular insights into the link between hepatocellular carcinoma and intratumoral fibrosis could lead to better ...

The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in ...